Fast Five Quiz: Cancer-Associated Venous Thromboembolism (VTE)

Kenneth A. Bauer, MD


March 17, 2020

According to the American Society of Clinical Oncology, hospitalized patients with acute illness or reduced mobility and active malignancy, and those with cancer undergoing major surgery, should be offered anticoagulant medications unless bleeding or other contraindications exist. Hospitalized patients with active malignancy but no additional risk factors may also be offered anticoagulant medications in the absence of bleeding or other contraindications. However, outpatients and patients admitted only for minor procedures, as well as those undergoing stem cell or bone marrow transplantation, should not be offered routine anticoagulant prophylaxis. Thromboprophylactic anticoagulation is not recommended to improve survival in patients with cancer but without established VTE.

Learn more about thromboprophylaxis in cancer-associated VTE.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: